Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v3-EN | Version v2-FR | |
---|---|---|
Language | English | French |
Date Updated | 2017-04-02 | 2017-03-13 |
Drug Identification Number | 02382296 | 02382296 |
Brand name | HEPARIN SODIUM INJECTION USP | HEPARIN SODIUM INJECTION USP |
Common or Proper name | HEPARIN | HEPARIN |
Company Name | PFIZER CANADA ULC | PFIZER CANADA ULC |
Ingredients | HEPARIN SODIUM | HEPARIN SODIUM |
Strength(s) | 1000UNIT | 1000UNIT |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INTRAVENOUS SUBCUTANEOUS | INTRAVENOUS SUBCUTANEOUS |
Packaging size | 25 x 10ML | 25 x 10ML |
ATC code | B01AB | B01AB |
ATC description | ANTITHROMBOTIC AGENTS | ANTITHROMBOTIC AGENTS |
Reason for discontinuation | Other (Please describe in comments) | Other (Please describe in comments) |
Anticipated discontinuation date | ||
Actual discontinuation date | 2017-04-01 | 2017-04-01 |
Remaining supply date | 2017-04-01 | 2017-04-01 |
Discontinuation status | Discontinued | To be discontinued |
Discontinuation decision reversal | no | no |
Tier 3 Status | No | No |
Information on remaining supply | ||
Company comments | Discontunation of product / Discontinuité du produit | Discontunation of product / Discontinuité du produit |
Health Canada comments |